Loading
Latest filing published 20 Mar 2026 for Oncopeptides AB, €431.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Stefan Norin (board member) discloses dealings in Oncopeptides AB to Finansinspektionen. Between 3 May 2024 and 19 March 2026, the trades on record add up to 4 filings.
The open-market record is one-sided, with 1 purchase worth €1,112 and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants.
On 20 March 2026 came the latest disclosure, a share grant for €431 in Oncopeptides AB. The last insider purchase was made public on 17 May 2024, 891 days ago. Filings reach the Finansinspektionen feed a median of 2 days after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations